beta-lapachone has been researched along with Blood Pressure, High in 4 studies
beta-lapachone: antineoplastic inhibitor of reverse transcriptase, DNA topoisomerase, and DNA polymerase
beta-lapachone : A benzochromenone that is 3,4-dihydro-2H-benzo[h]chromene-5,6-dione substituted by geminal methyl groups at position 2. Isolated from Tabebuia avellanedae, it exhibits antineoplastic and anti-inflammatory activities.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hypertension is one of the most common human diseases worldwide, and extensive research efforts are focused upon the identification and utilizing of novel therapeutic drug targets." | 5.37 | Activation of NAD(P)H:quinone oxidoreductase ameliorates spontaneous hypertension in an animal model via modulation of eNOS activity. ( Gang, GT; Hwang, JH; Kim, DH; Kim, YH; Kwak, TH; Lee, CH; Lee, IK; Noh, JR; Shong, M; Son, HY, 2011) |
| "Hypertension is one of the most common human diseases worldwide, and extensive research efforts are focused upon the identification and utilizing of novel therapeutic drug targets." | 1.37 | Activation of NAD(P)H:quinone oxidoreductase ameliorates spontaneous hypertension in an animal model via modulation of eNOS activity. ( Gang, GT; Hwang, JH; Kim, DH; Kim, YH; Kwak, TH; Lee, CH; Lee, IK; Noh, JR; Shong, M; Son, HY, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, YH | 4 |
| Hwang, JH | 4 |
| Kim, KS | 3 |
| Noh, JR | 4 |
| Gang, GT | 4 |
| Kim, SW | 1 |
| Jang, SP | 1 |
| Lee, SJ | 1 |
| Her, SH | 1 |
| Jeong, KH | 2 |
| Kwak, TH | 4 |
| Park, WJ | 1 |
| Balyasnikova, IV | 1 |
| Shong, M | 2 |
| Lee, CH | 4 |
| Oh, WK | 1 |
| Choi, HS | 1 |
| Lee, IK | 2 |
| Seo, Y | 1 |
| Nam, KH | 1 |
| Lee, HG | 1 |
| Kim, DH | 1 |
| Son, HY | 1 |
4 other studies available for beta-lapachone and Blood Pressure, High
| Article | Year |
|---|---|
NQO1 activation regulates angiotensin-converting enzyme shedding in spontaneously hypertensive rats.
Topics: Animals; Blood Pressure; Calcium; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cells, Culture | 2013 |
Enhanced activation of NAD(P)H: quinone oxidoreductase 1 attenuates spontaneous hypertension by improvement of endothelial nitric oxide synthase coupling via tumor suppressor kinase liver kinase B1/adenosine 5'-monophosphate-activated protein kinase-media
Topics: AMP-Activated Protein Kinases; Animals; Antihypertensive Agents; Aorta; Blood Pressure; Cell Line; C | 2014 |
NAD(P)H:quinone oxidoreductase 1 activation reduces blood pressure through regulation of endothelial nitric oxide synthase acetylation in spontaneously hypertensive rats.
Topics: Acetylation; Animals; Antihypertensive Agents; Blood Pressure; Cell Line; Disease Models, Animal; En | 2015 |
Activation of NAD(P)H:quinone oxidoreductase ameliorates spontaneous hypertension in an animal model via modulation of eNOS activity.
Topics: Acetylcholine; AMP-Activated Protein Kinases; Animals; Antihypertensive Agents; Blood Pressure; Calc | 2011 |